ABVC BioPharma Closes $3.39 Million Private Placement to Fund Operations and Settle Dispute

ABVC BioPharma Announces Closing of Private Placement Offering of Original Issue Discount Senior Convertible Promissory Notes for Gross Proceeds of $3.39 Million

Open the article to view the coverage from NewMediaWire

ABVC BioPharma Closes $3.39 Million Private Placement to Fund Operations and Settle Dispute

ABVC BioPharma's $3.39 million private placement of convertible notes will fund working capital, subsidiary development, and a $625,000 settlement with Lind Global Fund II LP, supporting its strategy to advance drug and device programs through independent financing. The post ABVC BioPharma Closes $3.39 Million Private Placement to Fund Operations and Settle Dispute appeared first on citybuzz.